fda label semaglutide naion warning 2025 US removes suicidal thoughts from weight-loss drugs The FDA sent a warning

Most weight loss occurs through a calorie deficit

After an application by plaintiffs to organize the case in a Multidistrict Litigation (MDL), the two largest defendants, Novo Nordisk and Eli Lilly, are split on their response to the application

The benefits of a dual-agonist injection include: Targeting two distinct gut hormone pathways for a stronger impact on satiety

The injection site should have no redness, swelling, scarring, bruising, or inflammation

They adhere to HIPAA regulations and maintain patient privacy standards

Otherwise, you might accidentally hit a muscle or blood vessel, which can be painful and cause bruising